USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: ACADUCEUS PHARMACEUTICS, INC.
City: CUPERTINO
State: CA
Zip+4: 95014-4956
Woman-Owned: Yes
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $495,988.00 3

Award List:

Targeted Prodrug Chemotherapy for Prostate Cancer

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Jenny C. Wu
Award Amount: $159,988.00
Abstract:
DESCRIPTION (provided by applicant): The ultimate goal of this SBIR proposal is to develop the novel pharmaceutical prodrug: DOX-PSASP-BBN- RGD as a molecular targeting chemotherapeutic agent for the treatment for prostate cancer. Prostate cancer is the mo st common cancer for men worldwide.… More

Dual Integrin and GRPR Targeted Radiotherapy of Prostate Cancer

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Jenny C. Wu
Award Amount: $100,000.00
Abstract:
DESCRIPTION (provided by applicant): The ultimate goal of this SBIR proposal is to develop novel radiopeptides as targeting agents for internal radiotherapy of prostate cancer. Prostate cancer is the most common cancer affecting men in the United States. C urrently, early stage prostate cancer is… More

Phage Display Peptide Probes for Imaging Early Response to Cancer Therapy

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Jenny C. Wu – 415-723-2753
Award Amount: $236,000.00
Abstract:
DESCRIPTION (provided by applicant): The ultimate goal of this SBIR proposal is to develop novel molecular imaging markers for monitoring tumor early response and efficacy to anti-angiogenic treatment regimens. Anti-angiogenic therapy represents an exciting advance in the management of cancer.… More